Search Results

Printer Friendly
Public Act Number: 280
Public Act Year: 2014
Document Type(s): MCLs
(13 results found)
Please note: on small devices, or if your browser window is not maximized, you may need to scroll horizontally to see the entire table
Document Type Description
Section 333.16233 Section Investigation; order to cease and desist; hearing; violation of order; summary suspension of license or registration; notice from federal agency.
Section 333.16241 Section Publishing list of names and addresses of disciplined individuals; distribution of compilation; report of disciplinary actions; report upon summary suspension of license; notice of revocation or suspension to patient or client; notice to employer or hospital; report.
Section 333.17702 Section Definitions; A to C.
Section 333.17704 Section Definitions; F to I.
Section 333.17706 Section Definitions; M, O.
Section 333.17707 Section Definitions; P.
Section 333.17709 Section Definitions; S to W.
Section 333.17742 Section Disclosure; "applicant" defined.
Section 333.17748 Section Pharmacy, manufacturer, wholesale distributor; or wholesale distributor-broker, license required; compounding services; renewal; designation of pharmacist in charge; joint responsibility; exemption; report of change in ownership, management, location, or PIC or facility manager; duties of pharmacist in charge; submission of fingerprints; criminal history check; exception; investigation or inspection of out-of-state applicant or compounding pharmacy; reimbursement for expenses.
Section 333.17748a Section Compounding services for sterile pharmaceuticals; accreditation; notification of complaint; maintenance and retention of records; resale of excess compounded pharmaceuticals prohibited; distribution of samples or complimentary starter doses; advertisement or promotion of compounding services; compounding pharmaceutical that is unavailable in marketplace; compounding and manufacturing at same location; rules.
Section 333.17748b Section Compounding nonsterile or sterile pharmaceuticals for prescriber or health facility or agency to administer to patients without prescription; authorization; report of adverse event; list of authorized pharmacies and pharmacists; selling or redispensing to prescriber or health facility or agency.
Section 333.17748c Section Compounding pharmaceutical; commercial availability.
Section 333.17748d Section Violation of MCL 333.17748a or 17748b; penality.